Background: Giardiasis is one of the most common causes of diarrheal disease worldwide and 5-nitroimidazoles (5-NI) are
the most commonly prescribed drugs for the treatment of giardiasis. We evaluated the efficacy of 5-nitroimidazoles (5-NI) in
the treatment of giardiasis in a systematic review of randomized controlled trials (RCTs).
Methodology/Principal Findings: We conducted a comprehensive literature search in PubMed-Medline, Scopus, Web of
Science and Cochrane Library for RCTs evaluating the efficacy of 5-NI vs. control (placebo or active treatment) on
parasitological cure in patients with parasitologically-demonstrated giardiasis. The search was performed in May 2013 with
no language restriction by two authors independently. The efficacy outcome was parasitological cure, and harmful
outcomes were abdominal pain, bitter or metallic taste, and headache. We included 30 RCTs (n = 3,930). There was a
significant and slightly higher response rate with 5-NI in giardiasis treatment (RR 1.06, 95%CI 1.02–1.11, p = 0.005). There was
high heterogeneity among studies (I2= 72%). The response rates for metronidazole, tinidazole and secnidazole were similar
(RR 1.05, 95%CI 1.01–1.09, p = 0.01; RR 1.32 95%CI 1.10–1.59, p = 0.003; and RR 1.18 95%CI 0.93–1.449, p = 0.18, respectively).
On subgroup analyses, the response rates did not vary substantially and high heterogeneity persisted (I2= 57%–80%).
Harmful outcomes were uncommon, and 5-NIs were associated with lower risk of abdominal pain, and higher risk of both
bitter or metallic taste and headache.
Conclusions: Studies investigating the efficacy of 5-NI in giardiasis treatment are highly heterogeneous. 5-NIs have a slightly
better efficacy and worse profile for mild harmful outcomes in the treatment of giardiasis in comparison to controls. Larger
high quality RCTs are needed to further assess efficacy and safety profiles of 5-NI.
Authors: Pasupuleti, Vinay; Escobedo, Angel Arturo; Deshpande, Abhishek; Thota, Priyaleela; Roman, Yuani; Hernandez, Adrian V.
Source: Public Library of Science (PLoS)
URL: http://hdl.handle.net/10757/316481
Furazolidone-resistant mutants were obtained from four clinical isolates of diarrhoeagenic Escherichia coli. The stability of the resistance and the frequency of mutation were established. The minimal inhibitory concentration of furazolidone, nitrofurantoin, nalidixic acid, ampicillin, chloramphenicol and tetracycline was established both in the presence and absence of the efflux pump inhibitor Phe-Arg-β-Naphtylamyde. The presence of mutations in the nitroreductase genes nfsA and nfsB was analysed by PCR; sequencing and their enzymatic activity was assessed by a spectrophotometric assay. Alterations in outer membrane proteins were studied by SDS-PAGE. The frequency of mutation ranged from <9.6 × 10-10 to 9.59 × 10-7 . Neither an effect on efflux pumps inhibited by Phe-Arg-β-Naphtylamyde nor cross-resistance with the antibiotics studied was observed. Nineteen mutants (52.94%) presented mutations in the nitroreductase-encoding genes: 17 in the nfsA gene (15 mutants with an internal stop codon, 2 with amino acid changes), 2 in the nfsB (all amino acid changes). Alterations in the outer membrane proteins OmpA and OmpW were also observed. Although more studies are necessary to find other resistance mechanisms, present data showed the low potential of selecting furazolidone-resistant mutants, together with the lack of cross-resistance with unrelated antimicrobial agents.
Authors: Martínez Puchol, Sandra; Gómes, Cláudia; Pons, Maria J.; Ruíz Roldan, Lidia; Torrents De La Peña, Alba; Ochoa, Theresa J.; Ruíz, Joaquim
Source: Acta pathologica, microbiologica et Immunológica Scandinavica (APMIS.)
URL: http://hdl.handle.net/10757/556955
Introduction: There is limited and controversial information regarding the
potential impact of depression on glycemic control. This study aims to
evaluate the association between depression and poor glycemic control. In
addition, the prevalence of depression and rates of poor glycemic control
were determined.
Methods: Cross-sectional study performed in the endocrinology unit of
two hospitals of ESSALUD in Peru. The outcome of interest was poor
glycemic control, evaluated by glycated hemoglobin (HbA1c: < 7%
versus ≥ 7%), whereas the exposure of interest was depression defined as
15 or more points in the Patient Health Questionnaire-9 tool.
The association of interest was evaluated using Poisson regression
models with robust standard errors reporting prevalence ratios (PR) and
95% confidence intervals (95% CI) adjusting for potential confounders.
Results: A total of 277 participants, 184 (66.4%) males, mean age 59.0
(SD: 4.8), and 7.1 (SD: 6.8) years of disease were analyzed. Only 31
participants (11.2%; 95% CI: 7.5%–14.9%) had moderately severe or
severe depression, whereas 70 (25.3%; 95% CI 20.3%–30.8%) had good
glycemic control. Depression increased the probability of having poor
glycemic control (PR = 1.32; 95% CI 1.15–1.51) after adjusting for several
potential confounders.
Conclusions: There is an association between depression and poor
glycemic control among type 2 diabetes patients. Our results suggest that
early detection of depression might be important to facilitate appropriate
glycemic control and avoid further metabolic complications.
Authors: Crispín Trebejo, Brenda; Robles Cuadros, María Cristina; Bernabé Ortiz, Antonio
Source: Asia-Pacific Psychiatry
URL: http://hdl.handle.net/10757/556689
PURPOSE:
To determine the prevalence of disability in Peru, explore dependency on caregiver's assistance and assess access to rehabilitation care.
METHOD:
Data from Disability National Survey (ENEDIS), including urban and rural areas, were analyzed. Disability was defined as a permanent limitation on movement, vision, communication, hearing, learning/remembering or social relationships. Dependency was defined as the self-reported need for a caregiver to help with daily activities; and access to rehabilitation care was defined as the self-report of any therapy for disabilities. Estimates and projections were calculated using sample strata, primary sampling units and population weights, and prevalence ratios (PRs) and 95%CI were reported.
RESULTS:
From 798 308 people screened, 37 524 (5.1%; 95%CI 4.9--5.2%) had at least one disability. A total of 37 117 were included in further analysis, mean age 57.8 (SD ± 24.1) years, 52.1% women. Dependency was self-reported by 14 980 (40.5%; 95%CI: 39.2-41.9%) individuals with disabilities. A family member, usually female, was identified as a caregiver in 94.3% (95%CI: 93.3-95.3%) of dependent participants. Only 2881 (10.7%; 95%CI: 9.7-11.9%) of people with disabilities reported access to rehabilitation care. Major inequality patterns of disability burden versus access to rehabilitation care were observed by age and education level. Older age groups had higher disability burden yet lower chances of access to rehabilitation care. Conversely, the higher the education level, the lesser the overall disability burden but also the higher chances of reporting receiving care. Private healthcare insurance doubled the probability of having access to rehabilitation compared with those without insurance.
CONCLUSIONS:
Approximately 1.6 million Peruvians have at least one disability, and 40% of them require assistance with daily activities. Informal caregiving, likely female and relative-provided, is highly common. Rehabilitation care access is low and inequitable. Our results signal a major need to implement strategies to guarantee the highest standard of health care for people with disabilities. Implications for Rehabilitation Major inequality patterns in terms of burden of disability versus access to rehabilitation care were observed: those groups who concentrate more disability reported receiving less rehabilitation care. Caregiving is mostly informal and provided by a direct relative, mainly a woman, who resigned to their usual activities in order to help care for the person with disability. As a result, there is a need to develop appropriate support and training for caregivers. Access to care services in Peru is low and inequitable, but especially for people with disabilities: they experience greater barriers when accessing healthcare services even in the case of having health insurance.
Authors: Bernabe Ortiz, Antonio; Diez Canseco, Francisco; Vásquez, Alberto; Miranda, J. Jaime
Source: (Disability and Rehabilitation (Disabil Rehabil)
URL: http://hdl.handle.net/10757/556094
BACKGROUND:
Enteropathogenic Escherichia coli (EPEC) strains are pediatric pathogens commonly isolated from both healthy and sick children with diarrhea in areas of endemicity. The aim of this study was to compare the bacterial load of EPEC isolated from stool samples from children with and without diarrhea to determine whether bacterial load might be a useful tool for further study of this phenomenon.
METHODS:
EPEC was detected by polymerase chain reaction (PCR) of colonies isolated on MacConkey plates from 53 diarrheal and 90 healthy children aged <2 years. DNA was isolated from stool samples by cetyltrimethylammonium bromide extraction. To standardize quantification by quantitative real-time PCR (qRT-PCR), the correlation between fluorescence threshold cycle and copy number of the intimin gene of EPEC E2348/69 was determined.
RESULTS:
The detection limit of qRT-PCR was 5 bacteria/mg stool. The geometric mean load in diarrhea was 299 bacteria/mg (95% confidence interval [CI], 77-1164 bacteria/mg), compared with 29 bacteria/mg (95% CI, 10-87 bacteria/mg) in control subjects (P = .016). Bacterial load was significantly higher in children with diarrhea than in control subjects among children <12 months of age (178 vs 5 bacteria/mg; P = .006) and among children with EPEC as the sole pathogen (463 vs 24 bacteria/mg; P = .006).
CONCLUSIONS:
EPEC load measured by qRT-PCR is higher in diarrheal than in healthy children. qRT-PCR may be useful to study the relationship between disease and colonization in settings of endemicity.
Authors: Barletta, Francesca; Ochoa, Theresa J.; Mercado, Erik H.; Ruiz, Joaquim; Ecker, Lucie; Lopez, Giovanni; Mispireta, Monica;Gil, Ana I.; Lanata, Claudio F.; Cleary, Thomas G.
Source: Clinical Infectious Diseases (Clin Infect Dis)
URL: http://hdl.handle.net/10757/556075